Top 5 Undervalued Stocks with P/E Ratios Below 20 – A Smart Investor’s Watchlist
Top 5 Undervalued Stocks : One of the most effective ways to determine whether a stock is undervalued or overvalued is by analyzing key financial metrics, especially the Price-to-Earnings (P/E) ratio. The P/E ratio compares a company’s share price to its earnings per share (EPS) and is widely used to assess stock valuation.
If a company’s P/E ratio is significantly higher than the industry average, it may indicate an overvalued stock, meaning investors are paying a premium for its earnings. Conversely, if the P/E ratio is much lower than the industry average, it could suggest that the stock is undervalued, presenting a potential buying opportunity.
Based on this valuation approach, here are five stocks with a P/E ratio of less than 20, making them attractive picks for investors looking for undervalued stocks.
1. Sigachi Industries Limited (NSE: SIGACHI)
- Market Cap: ₹1,278.7 Crore
- Current Stock Price: ₹39.68
- P/E Ratio: 18.5 (Industry P/E: 27)
- Q3 FY25 Revenue Growth: 25.2% YoY
- Q3 FY25 Net Profit Growth: 31.3% YoY
Company Overview:
Established in 1989, Sigachi Industries Limited specializes in the manufacturing of Micro Crystalline Cellulose Powder (MCCP), which is widely used in pharmaceuticals, food, and nutraceuticals. The company is one of India’s leading pre-formulation excipient manufacturers.
With its P/E ratio lower than the industry average, the stock appears undervalued. The company has also delivered strong revenue and profit growth, indicating robust financial health.
2. VST Industries Limited (NSE: VSTIND)
- Market Cap: ₹4,289.8 Crore
- Current Stock Price: ₹270.6
- P/E Ratio: 17.6 (Industry P/E: 25.3)
- Q3 FY25 Revenue Growth: 1.1% YoY
- Q3 FY25 Net Profit Growth: 152% YoY
Company Overview:
VST Industries is a well-established company in the tobacco and cigarette manufacturing sector. Despite the challenges in the industry, the company has demonstrated resilience with a remarkable 152% YoY growth in net profit in Q3 FY25.
The stock’s P/E ratio is significantly below the industry average, making it a potential investment opportunity for long-term investors.
3. Dynacons Systems & Solutions Limited (NSE: DYNACONS)
- Market Cap: ₹1,338 Crore
- Current Stock Price: ₹1,061.8
- P/E Ratio: 19.6 (Industry P/E: 29.1)
- Q3 FY25 Revenue Growth: 37% YoY
- Q3 FY25 Net Profit Growth: 38.5% YoY
Company Overview:
Dynacons Systems & Solutions is a leading IT infrastructure solutions provider in India. The company specializes in data center setup, network infrastructure, and system integration services.
With a P/E ratio lower than the industry average, strong revenue and profit growth, and the rising demand for IT services, Dynacons appears to be an undervalued stock with long-term potential.
4. Tejas Networks Limited (NSE: TEJASNET)
- Market Cap: ₹12,511 Crore
- Current Stock Price: ₹702
- P/E Ratio: 18.8 (Industry P/E: 20.1)
- Q3 FY25 Revenue Growth: 372% YoY
- Q3 FY25 Net Profit Growth: Turned profitable (₹166 Crore from a loss of ₹45 Crore in Q3 FY24)
Company Overview:
Tejas Networks, a part of the Tata Group, is a leading telecom and networking equipment manufacturer in India. The company provides solutions for wireless and wireline networks, making it a key player in India’s telecom growth story.
The company’s P/E ratio is slightly below the industry average, and its turnaround from loss to profit indicates a strong revival. The 372% YoY growth in revenue further solidifies its position as an undervalued stock.
5. Zydus Lifesciences Limited (NSE: ZYDUSLIFE)
- Market Cap: ₹88,166 Crore
- Current Stock Price: ₹867.3
- P/E Ratio: 19.4 (Industry P/E: 27)
- Q3 FY25 Revenue Growth: 17% YoY
- Q3 FY25 Net Profit Growth: 30% YoY
Company Overview:
Zydus Lifesciences is a leading pharmaceutical company with a strong presence in active pharmaceutical ingredients (APIs) and human formulations.
With a P/E ratio significantly lower than the industry average, combined with strong revenue and profit growth, Zydus is an attractive pick for investors seeking undervalued pharmaceutical stocks.
Comparison of Key Financial Ratios
| Stock Name | Market Cap (₹ Crore) | Current Price (₹) | P/E Ratio | Industry P/E | Revenue Growth (YoY) | Net Profit Growth (YoY) |
|---|---|---|---|---|---|---|
| Sigachi Industries | 1,278.7 | 39.68 | 18.5 | 27 | 25.2% | 31.3% |
| VST Industries | 4,289.8 | 270.6 | 17.6 | 25.3 | 1.1% | 152% |
| Dynacons Systems | 1,338 | 1,061.8 | 19.6 | 29.1 | 37% | 38.5% |
| Tejas Networks | 12,511 | 702 | 18.8 | 20.1 | 372% | Turned Profitable |
| Zydus Lifesciences | 88,166 | 867.3 | 19.4 | 27 | 17% | 30% |
Final Thoughts
These five stocks exhibit strong financial growth and P/E ratios lower than their industry averages, indicating that they are currently undervalued. While the P/E ratio alone is not the only metric to consider when investing, it serves as a useful indicator for identifying potential value stocks.
Investors looking for undervalued opportunities should conduct further research, analyze business fundamentals, and assess industry trends before making investment decisions.
Would you consider adding any of these stocks to your portfolio? Let us know in the comments below!
For more market insights, follow our news.
Stay tuned for more updates and insights on the stock market! For more insights on investing in the Indian stock market, check out resource like ET, NSE India.
Disclaimer: This blog post is for informational purposes only and should not be considered financial advice. Investors should conduct thorough research and consult with a qualified financial advisor before making any investment decisions.